Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
13 studies found for:    zerenex
Show Display Options
Rank Status Study
1 Recruiting Ferric Citrate for the Transition From CKD Stage 4/5 to CKD Stage 5D
Conditions: Chronic Kidney Disease;   Hyperphosphatemia;   Iron Deficiency Anemia;   Renal Insufficiency
Intervention: Drug: Ferric Citrate
2 Completed
Has Results
A Safety and Tolerability Study of Zerenex (Ferric Citrate) in Patients With End-Stage Renal Disease (ESRD)
Conditions: Hyperphosphatemia;   End-stage Renal Disease
Intervention: Drug: ferric citrate
3 Completed Ferric Citrate in Patients With End-Stage Renal Disease on Dialysis
Conditions: ESRD;   Hyperphosphatemia
Interventions: Drug: Calcium acetate, sevelamer carbonate;   Drug: Ferric citrate
4 Recruiting A Study of Ferric Citrate to Improve Inflammation and Lipid Levels
Conditions: End Stage Renal Disease;   Hyperphosphatemia;   Chronic Inflammation
Intervention: Drug: Ferric Citrate
5 Completed Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
Conditions: Iron Deficiency;   Iron Deficiency Anemia
Interventions: Drug: Ferric Citrate;   Drug: Placebo
6 Recruiting Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency
Conditions: Chronic Kidney Disease;   Iron Deficiency;   Anemia
Interventions: Drug: ferric citrate;   Drug: ferrous sulfate
7 Completed
Has Results
A 58-Week Safety and Efficacy Trial of Ferric Citrate in Patients With ESRD on Dialysis
Conditions: Hyperphosphatemia;   Kidney Failure
Intervention: Drug: ferric citrate, ca acetate, sevelamer carbonate, placebo
8 Completed KRX-0502 (Ferric Citrate) for the Treatment of IDA in Adult Subjects With NDD-CKD
Condition: Anemia of Chronic Kidney Disease
Interventions: Drug: ferric citrate;   Drug: Placebo
9 Completed A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of the Effects of Ferric Citrate in Subjects With End Stage Renal Disease
Conditions: Hyperphosphatemia;   End Stage Renal Disease;   ESRD
Intervention: Drug: ferric citrate
10 Completed
Has Results
Trial of a New Formulation of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease
Conditions: Hyperphosphatemia;   End-stage Renal Disease;   Renal Failure Chronic Requiring Hemodialysis
Intervention: Drug: ferric citrate
11 Completed
Has Results
A Long-Term Safety Extension Trial of Ferric Citrate in Patients With End-Stage Renal Disease (ESRD) on Dialysis
Conditions: End Stage Renal Disease;   Kidney Failure;   Renal Failure;   Hyperphosphatemia;   ESRD
Intervention: Drug: ferric citrate
12 Completed
Has Results
A 4-Week Dose-Ranging and Efficacy Trial of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease
Conditions: Hyperphosphatemia;   End-Stage Renal Disease
Intervention: Drug: ferric citrate
13 Completed A Pilot Study of KRX-0502 (Ferric Citrate, Administered Without Food, in Treating Iron-deficiency Anemia
Condition: Anemia of Chronic Kidney Disease
Intervention: Drug: KRX-0502

Indicates status has not been verified in more than two years